Oliveira Josenilson Campos de, Siviero-Miachon Adriana A, Spinola-Castro Angela Maria, Belangero Vera Maria Santoro, Guerra-Junior Gil
Clínica Médica, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas, SP, Brazil.
Arq Bras Endocrinol Metabol. 2008 Jul;52(5):783-91. doi: 10.1590/s0004-27302008000500010.
Growth failure is frequent and a clinically important issue in children with chronic kidney disease (CKD). Many factors contribute to impaired growth in these children, including abnormalities in the growth hormone (GH)--insulin-like growth factor 1 (IGF-1) axis, malnutrition, acidosis, renal bone disease and glucocorticoid associated treatment. The management of growth failure in children with CKD is complicated by the presence of other-disease related complications requiring medical intervention. Despite evidence of GH efficacy and safety in this population, this therapy is still underutilized. This review shows the impact, the causes and the treatment of growth failure in children with CKD.
生长发育迟缓在慢性肾脏病(CKD)患儿中很常见,且是一个具有临床重要性的问题。许多因素导致这些患儿生长发育受损,包括生长激素(GH)-胰岛素样生长因子1(IGF-1)轴异常、营养不良、酸中毒、肾性骨病以及糖皮质激素相关治疗。CKD患儿生长发育迟缓的管理因存在需要医学干预的其他疾病相关并发症而变得复杂。尽管有证据表明生长激素疗法在该人群中有效且安全,但这种疗法仍未得到充分利用。本综述阐述了CKD患儿生长发育迟缓的影响、原因及治疗方法。